Skip to main content
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
17.41
+0.15 (0.87%)
At close: Dec 5, 2025, 4:00 PM EST
17.07
-0.34 (-1.95%)
After-hours: Dec 5, 2025, 7:48 PM EST

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $12.77M in the quarter ending September 30, 2025, with 38.54% growth. This brings the company's revenue in the last twelve months to $181.54M, up 1,112.27% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

Revenue (ttm)
$181.54M
Revenue Growth
+1,112.27%
P/S Ratio
7.88
Revenue / Employee
$1,354,761
Employees
134
Market Cap
1.13B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

GLUE News

More News